Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Katherine S Ventre

Showing results (1-10 of 9) with videos related to

Pageof 1
Sort By:
Trends in Cancer|June 18, 2022
Lymph node metastasis fuels systemic diseaseKatherine S Ventre, Triantafyllia Karakousi, Amanda W Lund
Trends in Cancer|October 20, 2023
The tumor-draining lymph node as a reservoir for systemic immune surveillanceInes Delclaux, Katherine S Ventre, Dennis Jones, et al.
Science Immunology|June 7, 2024
Lymphatic vessel transit seeds cytotoxic resident memory T cells in skin draining lymph nodesTaylor A Heim, Austin C Schultz, Ines Delclaux, et al.
Biorxiv : the Preprint Server for Biology|February 6, 2026
NF1 Loss Remodels Tumor Niches for Immune EvasionMilad Ibrahim, Irineu Illa-Bochaca, Tara Muijlwijk, et al.
Biorxiv : the Preprint Server for Biology|May 18, 2026
Lymphatic egress recycles tumor-experienced effector CD8 T cells to sustain immune surveillanceInes Delclaux, Katherine S Ventre, Naomi R Besson, et al.
Cancer Immunology Research|October 25, 2018
Altered Binding of Tumor Antigenic Peptides to MHC Class I Affects CD8<sup>+</sup> T Cell-Effector ResponsesEleanor Clancy-Thompson, Christine A Devlin, Paul M Tyler, et al.
Journal of Immunology (Baltimore, Md. : 1950)|March 7, 2023
cIAP1/2 Antagonism Induces Antigen-Specific T Cell-Dependent ImmunityKatherine S Ventre, Kevin Roehle, Elisa Bello, et al.
Cancer Discovery|May 4, 2021
Inhibition of CDK4/6 Promotes CD8 T-cell Memory FormationMax Heckler, Lestat R Ali, Eleanor Clancy-Thompson, et al.
Science Translational Medicine|May 20, 2021
cIAP1/2 antagonism eliminates MHC class I-negative tumors through T cell-dependent reprogramming of mononuclear phagocytesKevin Roehle, Li Qiang, Katherine S Ventre, et al.
Pageof 1

Showing results (1-10 of 9) with videos related to

Sort By:
Pageof 1
Trends in Cancer|June 18, 2022
Lymph node metastasis fuels systemic diseaseKatherine S Ventre, Triantafyllia Karakousi, Amanda W Lund
Trends in Cancer|October 20, 2023
The tumor-draining lymph node as a reservoir for systemic immune surveillanceInes Delclaux, Katherine S Ventre, Dennis Jones, et al.
Science Immunology|June 7, 2024
Lymphatic vessel transit seeds cytotoxic resident memory T cells in skin draining lymph nodesTaylor A Heim, Austin C Schultz, Ines Delclaux, et al.
Biorxiv : the Preprint Server for Biology|February 6, 2026
NF1 Loss Remodels Tumor Niches for Immune EvasionMilad Ibrahim, Irineu Illa-Bochaca, Tara Muijlwijk, et al.
Biorxiv : the Preprint Server for Biology|May 18, 2026
Lymphatic egress recycles tumor-experienced effector CD8 T cells to sustain immune surveillanceInes Delclaux, Katherine S Ventre, Naomi R Besson, et al.
Cancer Immunology Research|October 25, 2018
Altered Binding of Tumor Antigenic Peptides to MHC Class I Affects CD8<sup>+</sup> T Cell-Effector ResponsesEleanor Clancy-Thompson, Christine A Devlin, Paul M Tyler, et al.
Journal of Immunology (Baltimore, Md. : 1950)|March 7, 2023
cIAP1/2 Antagonism Induces Antigen-Specific T Cell-Dependent ImmunityKatherine S Ventre, Kevin Roehle, Elisa Bello, et al.
Cancer Discovery|May 4, 2021
Inhibition of CDK4/6 Promotes CD8 T-cell Memory FormationMax Heckler, Lestat R Ali, Eleanor Clancy-Thompson, et al.
Science Translational Medicine|May 20, 2021
cIAP1/2 antagonism eliminates MHC class I-negative tumors through T cell-dependent reprogramming of mononuclear phagocytesKevin Roehle, Li Qiang, Katherine S Ventre, et al.
Pageof 1